Eli Lilly Expands Zepbound Vial Options and New Savings for Self-Pay Patients As of February 25, 2025, Eli Lilly and Company has created a self-pay pharmacy component of LillyDirect where patients with a valid, on-label, electronic prescription from a health care provider of their choice can purchase Zepbound 2.5, 5, 7.5, and 10 mg vials
The near-balanced peptide was shown to be ~2-fold less potent at GLP-1R and ~10 fold less potent at GCGR than native ligands in cAMP synthesis ( vs control groups
Youll see a yellow bar and plunger slowly move down the view window
A tailored IV experience built around your schedule, symptoms, goals, and provider guidance
That would not meet the evidentiary threshold for a poster presentation at most medical conferences